Jump to content

Coagulation: Difference between revisions

From MedLabWiki
No edit summary
No edit summary
Line 132: Line 132:


300ul citrate
300ul citrate
Coagulation Testing
{| class="wikitable"
|+
!Test
!Test Method
!Causes of Abnormal Results
!RI
|-
|PT/INR (Prothrombin Time)
|
* Citrated PPP (platelet poor plasma)
* Calcium thromboplastin added
* Measured optically or mechanically
** Optical: light scattered as fibrin strands form
** Mechanical: magnetic balls oscillates, movement impeded by clot
|
|11.5-13.5s
INR: 0.9-1.2
|-
|APTT
|
* Citrated PPP mixed with APTT reagent
* Activation of factor XII and XI
* Calcium then added to activate factor IX and VIII
* Factor X activated, causing cascade to activate Factor II and I, forming fibrin clot
|
|23-35 s
|-
|Fibrinogen (Clauss Assay)
|
* Clauss assay uses reference plasma samples with known concentrations of fibrinogen
* Run thrombin time (high thrombin concentration) and plot results of concentration vs. time
* Patient samples can then be run and compared to the curve to determine fibrinogen concentration
|
|
|-
|Thrombin Time
|
* Citrated PPP
* Low concentration of thrombin added to cleave fibrinogen -> fibrin
* Measure time to form fibrin clot
|
* Congential fibrinogen deficiencies
* Acquired fibrinogen deficincies
* Unfractionated heparin
* Direct thrombin inhibitors (dabigatran, apixaban)
|
|-
|Unfractionated Heparin/Anti-Xa Assay
|
|
|
|-
|Factor Assays
|
|
|
|}

Revision as of 18:39, 27 January 2025

Factors II, V, VIII, HMWK -> cofactors

Factors II, VII, 9-12, Prekallikrein -> serine proteases

Vitamin K Dependent Factors

  • Serine Proteases
    • Factors II, VII, IX, X
    • Regulatory control proteins C, S, Z
Factor Other Names Pathway(s) Role Location of Synthesis
I Fibrinogen Common
II Prothrombin Common
III Tissue Factor (TF)
IV Ca2+
V Labile factor Common
VII Stable factor Extrinsic
VIII Anti-hemophilic factor Intrinsic
IX Christmas Factor Intrinsic
X Stuart-Prower Factor Common
XI PTA (Plasma Thromboplastin Antecedent) Intrinsic
XII Hageman Factor Intrinsic
XIII Fibrin Stabilizing Factor (FSF) Crosslinks adjacent fibrin strand D-domains to make an insoluble polymer
VWF
HMWK High Molecular Weight

Stages of Hemostasis

  1. Primary hemostasis
  2. Secondary hemostasis
  3. Fibrin clot formation
  4. Coagulation inhibition

Protein Z

  • Z-dependent protease inhibitor (ZPI)
  • Protein Z enhances ZPI activity
    • inhibits factor X and XI

Restoring Blood Flow

  • Fibrinolytic proteins
    • Plasminogen
      • Converted into plasmin by TPA and UPA
      • Plasmin helps restore blood flow
    • TPA
    • UPA

1.85*10^-3 x (100-HCT) x v

300ul citrate

Coagulation Testing

Test Test Method Causes of Abnormal Results RI
PT/INR (Prothrombin Time)
  • Citrated PPP (platelet poor plasma)
  • Calcium thromboplastin added
  • Measured optically or mechanically
    • Optical: light scattered as fibrin strands form
    • Mechanical: magnetic balls oscillates, movement impeded by clot
11.5-13.5s

INR: 0.9-1.2

APTT
  • Citrated PPP mixed with APTT reagent
  • Activation of factor XII and XI
  • Calcium then added to activate factor IX and VIII
  • Factor X activated, causing cascade to activate Factor II and I, forming fibrin clot
23-35 s
Fibrinogen (Clauss Assay)
  • Clauss assay uses reference plasma samples with known concentrations of fibrinogen
  • Run thrombin time (high thrombin concentration) and plot results of concentration vs. time
  • Patient samples can then be run and compared to the curve to determine fibrinogen concentration
Thrombin Time
  • Citrated PPP
  • Low concentration of thrombin added to cleave fibrinogen -> fibrin
  • Measure time to form fibrin clot
  • Congential fibrinogen deficiencies
  • Acquired fibrinogen deficincies
  • Unfractionated heparin
  • Direct thrombin inhibitors (dabigatran, apixaban)
Unfractionated Heparin/Anti-Xa Assay
Factor Assays